Fertility · Ovarian aging

CoQ10 for egg quality: what the evidence actually shows.

Egg quality declines with age largely because oocyte mitochondria decline with age. CoQ10 — specifically its reduced form ubiquinol — is one of the few supplements with a genuine mechanistic and clinical case for improving that. Here is what the evidence actually says.

Why CoQ10 matters for egg quality

Every oocyte in a woman's body contains hundreds of thousands of mitochondria — the highest mitochondrial density of any cell type. Mitochondrial ATP output is what powers meiotic spindle formation, chromosomal segregation, and early embryonic cleavage. As mitochondrial function declines with age, aneuploidy (chromosomal errors) rises and embryo quality drops.

CoQ10 (Coenzyme Q10) is a critical cofactor in mitochondrial electron transport. Endogenous CoQ10 levels decline with age — mirroring the decline in oocyte quality. Supplementing CoQ10, particularly the reduced form (ubiquinol), restores mitochondrial substrate availability and improves oocyte energetics.

What the evidence actually shows

Bentov et al. (Fertility and Sterility, 2010, 2014): CoQ10 supplementation in women over 35 improved oocyte mitochondrial function and reduced aneuploidy in mouse and preliminary human data.
Xu et al. (Reproductive Biology and Endocrinology, 2018): randomized trial of CoQ10 pretreatment in poor-responder IVF patients — significantly higher fertilization rate, higher high-quality embryo rate, and higher clinical pregnancy rate vs control.
Giannubilo et al. (Antioxidants, 2018): CoQ10 improved follicular-fluid antioxidant capacity in women undergoing IVF.
Florou et al. (JARG, 2020) meta-analysis: CoQ10 supplementation in poor-responder IVF patients was associated with higher clinical pregnancy rates than placebo.
PCOS RCT data: CoQ10 improved ovulation and pregnancy rates in clomiphene-resistant PCOS.

The evidence is strongest for women over 35, women with diminished ovarian reserve, and women undergoing IVF as a poor-responder. It is less specific for younger fertile women — though the safety profile makes it a reasonable general supplement in the preconception window.

The dose and timing that studies use

Form: ubiquinol (reduced CoQ10). More bioavailable than ubiquinone, especially above age 40.
Dose: 600 mg per day, typically taken as 200 mg three times daily with a fat-containing meal (CoQ10 is fat-soluble).
Duration: a minimum of 60 days, ideally 90 days, before the cycle you're trying to conceive in or before IVF egg retrieval — because oocyte maturation takes ~90 days.
Timing with IVF: most reproductive endocrinologists continue CoQ10 through stimulation and pause it only if specifically instructed.

Where CoQ10 fits in a broader egg-quality protocol

CoQ10 (ubiquinol) 600 mg/day for 60–90 days before conception.
Prenatal with active methylated folate (5-MTHF) 400–1000 mcg.
Omega-3 (EPA/DHA) at least 1000 mg/day.
Vitamin D repletion to a serum 25(OH)D level ≥ 40 ng/mL.
Melatonin 3 mg at bedtime (evidence for oocyte antioxidant protection).
Consistent sleep, resistance training, and avoidance of environmental disruptors (BPA, phthalates, smoking, heavy alcohol).

None of these is a substitute for a fertility workup. If you have been trying to conceive for 12 months (or 6 months at age 35+), the highest-yield next step is a clinical evaluation — Kindr Fertility can help.

Safety

CoQ10 has an excellent safety record at doses up to 1200 mg/day. The most common side effect is mild GI upset, usually resolved by taking with food or splitting the dose. There are no significant drug interactions at typical doses; check with your clinician if you take warfarin or blood-pressure medications.

Sources

Bentov Y, Casper RF. The aging oocyte — can mitochondrial function be improved? Fertility and Sterility. 2013.
Xu Y et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in poor-responder young women. Reproductive Biology and Endocrinology. 2018.
Florou P et al. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology? Meta-analysis. JARG. 2020.
Giannubilo SR et al. CoQ10 supplementation in patients undergoing IVF-ET. Antioxidants. 2018.
ASRM Practice Committee: Female age-related fertility decline. Fertility and Sterility.

Frequently asked questions

Does CoQ10 improve egg quality?

Randomized and observational data suggest CoQ10 (ubiquinol) supplementation for at least 60–90 days before an IVF or IUI cycle is associated with improved oocyte mitochondrial function, higher fertilization rates, and improved embryo quality in women over 35 — particularly women with diminished ovarian reserve. It is not a fertility cure, but the evidence base is stronger than for most fertility supplements.

What is the best CoQ10 dose for egg quality?

The most commonly studied dose is 200 mg of ubiquinol three times daily (600 mg/day total) for a minimum of 60 days, ideally 90 days, before conception attempts or an IVF cycle. Some protocols use 400–800 mg/day. Ubiquinol (the reduced, more bioavailable form) is preferred over ubiquinone above age 40.

How long does CoQ10 take to improve egg quality?

Because an egg takes ~90 days to mature from a primordial follicle, CoQ10 needs to be taken for a minimum of 60–90 days before egg retrieval or the conception cycle to influence that batch of eggs. Consistent daily dosing matters more than mega-dosing.

Ubiquinol vs ubiquinone for egg quality?

Ubiquinol is the reduced (active) form and has better bioavailability, especially above age 40 when the body's conversion of ubiquinone → ubiquinol slows. For egg quality protocols, most fertility clinicians recommend ubiquinol.

Is CoQ10 safe to take while trying to conceive?

CoQ10 has an excellent safety profile at doses up to 1200 mg/day. Mild GI upset is the most common side effect. It should be paused during active IVF stimulation only if your reproductive endocrinologist advises; most allow continuation.

Does CoQ10 help with PCOS or diminished ovarian reserve?

Yes — the mitochondrial dysfunction hypothesis applies to both. Small RCTs in PCOS and in diminished ovarian reserve populations have shown improvements in ovulation rates, oocyte quality markers, and pregnancy rates with CoQ10 supplementation.

Considering a physician-supervised longevity protocol? Kindr Health evaluates peptide therapy as part of personalized perimenopause and menopause care.

Request your Longevity Consult →

Medically reviewed by Kindr Health Clinical Team · Last reviewed 2026-06-19. Compounded medications are prepared by FDA-registered 503A pharmacies and are not FDA-approved drug products.